IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 325 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $337 | -99.8% | 9,422 | +72.1% | 0.03% | +10.0% |
| Q2 2022 | $203,000 | -50.1% | 5,475 | -59.0% | 0.03% | -41.2% |
| Q4 2021 | $407,000 | -45.9% | 13,368 | -15.6% | 0.05% | -59.2% |
| Q3 2020 | $752,000 | +97.9% | 15,842 | +151.9% | 0.12% | +184.1% |
| Q4 2019 | $380,000 | -70.0% | 6,288 | -68.1% | 0.04% | -69.0% |
| Q2 2019 | $1,265,000 | +3.2% | 19,690 | +30.4% | 0.14% | +14.5% |
| Q1 2019 | $1,226,000 | +26.7% | 15,100 | -15.6% | 0.12% | +10.7% |
| Q4 2018 | $968,000 | -27.9% | 17,900 | -44.4% | 0.11% | +67.2% |
| Q2 2018 | $1,342,000 | -44.8% | 32,200 | -41.7% | 0.07% | -48.1% |
| Q1 2018 | $2,433,000 | +0.6% | 55,200 | +14.8% | 0.13% | -12.2% |
| Q4 2017 | $2,419,000 | +99.8% | 48,093 | +101.3% | 0.15% | +77.1% |
| Q3 2017 | $1,211,000 | +10.5% | 23,893 | +10.9% | 0.08% | +15.3% |
| Q2 2017 | $1,096,000 | +105.6% | 21,545 | +93.4% | 0.07% | +125.0% |
| Q4 2016 | $533,000 | – | 11,141 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,136 | $133,749 | 7.12% |
| Bellevue Group AG | 9,743,900 | $368,027,103 | 4.88% |
| M28 Capital Management LP | 126,300 | $4,770,351 | 4.55% |
| Sicart Associates LLC | 246,258 | $9,301,165 | 3.28% |
| Camber Capital Management LP | 1,925,000 | $72,707 | 2.49% |
| Privium Fund Management B.V. | 148,807 | $5,557,941 | 2.11% |
| Deep Track Capital, LP | 1,205,773 | $45,542,046 | 1.91% |
| BVF INC/IL | 1,121,809 | $42,370,726 | 1.79% |
| Orbimed Advisors | 1,993,600 | $75,298,272 | 1.44% |
| Parkman Healthcare Partners LLC | 141,115 | $5,329,914 | 1.42% |